bobistheowl
BANNED
- Joined
- Oct 14, 2014
- Messages
- 1,935
I can understand the source of the children's fears. Spike TV has been airing 12 Monkeys twice a day, for the past week. That's 168 monkeys.
- Thread starter Louiloui
- Start date
oldguyzer
Reviewer
- Joined
- Jun 19, 2011
- Messages
- 15,067
Not true...bacon belongs in every thread.
oldguyzer
Reviewer
- Joined
- Jun 19, 2011
- Messages
- 15,067
You were bent over? :biggrin2:
oldguyzer
Reviewer
- Joined
- Jun 19, 2011
- Messages
- 15,067
Guess I have to order a few sexy nurses for Friday! :YMAPPLAUSE:
papasmerf
Senior Member
- Joined
- Aug 9, 2010
- Messages
- 33,614
Then you woke up.
- Thread starter
- #87
[h=1]India isolates man with Ebola-infected semen[/h]
https://us.cnn.com/2014/11/19/world/asia/india-ebola-semen/index.html?sr=sharebar_twitter
https://us.cnn.com/2014/11/19/world/asia/india-ebola-semen/index.html?sr=sharebar_twitter
https://www.nytimes.com/2014/12/08/health/ebola-doctor-ian-crozier-return-from-the-edge-of-death-.html?_r=1
[h=1]After Nearly Claiming His Life, Ebola Lurked in a Doctor’s Eye[/h]
Before he contracted Ebola, Dr. Ian Crozier had two blue eyes. After he was told he was cured of the disease, his left eye turned green. CreditEmory Eye Center
ATLANTA — When Dr. Ian Crozier was released from Emory University Hospital in October after a long, brutal fight with Ebola that nearly ended his life, his medical team thought he was cured. But less than two months later, he was back at the hospital with fading sight, intense pain and soaring pressure in his left eye.
Test results were chilling: The inside of Dr. Crozier’s eye was teeming with Ebola.
His doctors were amazed. They had considered the possibility that the virus had invaded his eye, but they had not really expected to find it. Months had passed since Dr. Crozier became ill while working in an Ebola treatment ward in Sierra Leone as a volunteer for the World Health Organization. By the time he left Emory, his blood was Ebola-free. Although the virus may persist in semen for months, other body fluids were thought to be clear of it once a patient recovered. Almost nothing was known about the ability of Ebola to lurk inside the eye.
[h=1]After Nearly Claiming His Life, Ebola Lurked in a Doctor’s Eye[/h]
Before he contracted Ebola, Dr. Ian Crozier had two blue eyes. After he was told he was cured of the disease, his left eye turned green. CreditEmory Eye Center
ATLANTA — When Dr. Ian Crozier was released from Emory University Hospital in October after a long, brutal fight with Ebola that nearly ended his life, his medical team thought he was cured. But less than two months later, he was back at the hospital with fading sight, intense pain and soaring pressure in his left eye.
Test results were chilling: The inside of Dr. Crozier’s eye was teeming with Ebola.
His doctors were amazed. They had considered the possibility that the virus had invaded his eye, but they had not really expected to find it. Months had passed since Dr. Crozier became ill while working in an Ebola treatment ward in Sierra Leone as a volunteer for the World Health Organization. By the time he left Emory, his blood was Ebola-free. Although the virus may persist in semen for months, other body fluids were thought to be clear of it once a patient recovered. Almost nothing was known about the ability of Ebola to lurk inside the eye.
U
User-E
Guest
RED said:
Ebola Researchers Take New Look at Risk of Sexual Transmission
Concerned about the potential for sexual transmission of Ebola, international health officials are investigating new reports of suspected cases and beginning studies to determine how often and how long the virus remains active in semen. And, for now, they are warning Ebola survivors to practice protected sex indefinitely.
A few possible cases of sexual transmission surfaced during the peak of the epidemic in West Africa, but little follow-up occurred then. Now, with new infections down to around three dozen a week across the three affected countries, medical investigators are focused on two women who died of the disease last month — one in Liberia and the other in Sierra Leone.
The women had no known risk factors, but they did have male partners who had survived Ebola last year, suggesting that the virus could be active in semen longer than researchers had previously detected, and that it could spread through sexual activity.
https://www.nytimes.com/2015/04/17/...-new-look-at-risk-of-sexual-transmission.html
W
Wanker
Guest
Scientists say a made-in-Canada vaccine could be the beginning of the end of the Ebola outbreak.
A new study says the vaccine designed by scientists at Canada’s National Microbiology Laboratory in Winnipeg induces a quick and highly protective response against the deadly virus.
This is the first time an experimental Ebola vaccine has proven effective.
Thierry Baldet, a senior program specialist at the International Development Research Centre who helped create the vaccine, said he’s extremely proud Canada played such a prominent role.
“It’s really important to have a tool against these infectious diseases and to stop the ongoing outbreak in Guinea and Sierra Leone,” he said. “If we protect the people in Africa, we avoid such introduction of infected people in the U.S. or Europe.”
The vaccine is geared towards the prevention of the virus infection.
“It’s not a drug, it’s not treatment, it’s a prevention tool,” said Baldet, who has over 20 years’ experience in research, surveillance and control of infectious diseases in Africa.
The results from the trial in Guinea are persuasive, says senior study author Marie-Paule Kieny, the World Health Organization’s point person for the development of Ebola vaccines and drugs.
“We have nobody in the 2,000 or so people who have been vaccinated (early) who have had an Ebola (diagnosis) 10 days after the vaccination. Nobody, zero,” she said.
Kieny said discussions will need to take place with the government of Sierra Leone to see if it wants to employ a ring vaccination approach in a bid to finally snuff out the 19-month-old West African outbreak.
Pharmaceutical giant Merck and NewLink Genetics, a biotech firm based in Ames, Iowa, are developing the rVSV-ZEBOV vaccine commercially.
The good news comes a week before the one-year anniversary of the day WHO declared the unprecedented West African outbreak a global public health emergency.
There have been nearly 28,000 cases and nearly 11,300 deaths.
Closer to home, provincial and federal health agencies weighed in on the vaccine results.
“Although it is still early, we will all be watching closely and hoping that today’s news represents a turning point in the fight against Ebola,” Ontario Health Minister Dr. Eric Hoskins said.
Health Canada called the results “promising.”
[email protected]
— With files from The Canadian Press
https://www.torontosun.com/2015/07/31/canadian-ebola-vaccine-shows-promise
A new study says the vaccine designed by scientists at Canada’s National Microbiology Laboratory in Winnipeg induces a quick and highly protective response against the deadly virus.
This is the first time an experimental Ebola vaccine has proven effective.
Thierry Baldet, a senior program specialist at the International Development Research Centre who helped create the vaccine, said he’s extremely proud Canada played such a prominent role.
“It’s really important to have a tool against these infectious diseases and to stop the ongoing outbreak in Guinea and Sierra Leone,” he said. “If we protect the people in Africa, we avoid such introduction of infected people in the U.S. or Europe.”
The vaccine is geared towards the prevention of the virus infection.
“It’s not a drug, it’s not treatment, it’s a prevention tool,” said Baldet, who has over 20 years’ experience in research, surveillance and control of infectious diseases in Africa.
The results from the trial in Guinea are persuasive, says senior study author Marie-Paule Kieny, the World Health Organization’s point person for the development of Ebola vaccines and drugs.
“We have nobody in the 2,000 or so people who have been vaccinated (early) who have had an Ebola (diagnosis) 10 days after the vaccination. Nobody, zero,” she said.
Kieny said discussions will need to take place with the government of Sierra Leone to see if it wants to employ a ring vaccination approach in a bid to finally snuff out the 19-month-old West African outbreak.
Pharmaceutical giant Merck and NewLink Genetics, a biotech firm based in Ames, Iowa, are developing the rVSV-ZEBOV vaccine commercially.
The good news comes a week before the one-year anniversary of the day WHO declared the unprecedented West African outbreak a global public health emergency.
There have been nearly 28,000 cases and nearly 11,300 deaths.
Closer to home, provincial and federal health agencies weighed in on the vaccine results.
“Although it is still early, we will all be watching closely and hoping that today’s news represents a turning point in the fight against Ebola,” Ontario Health Minister Dr. Eric Hoskins said.
Health Canada called the results “promising.”
[email protected]
— With files from The Canadian Press
https://www.torontosun.com/2015/07/31/canadian-ebola-vaccine-shows-promise
Similar threads
